Key Points
- Insider sale: On March 9 SVP Mark Brosius sold 645 shares of Intuitive Surgical at an average price of $485.01 for about $312,831, adding to several recent disposals (including 4,500 shares on Dec. 12).
- After these transactions Brosius' position declined by 28.57%
- Earnings and analyst view: Intuitive beat Q4 estimates (EPS $2.53 vs $2.27; revenue $2.87B vs $2.72B, +18.8% YoY) and carries a MarketBeat consensus of "Moderate Buy" with an average target of $615.86 and several firm targets up to $750.
Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) SVP Mark Brosius sold 645 shares of the business's stock in a transaction on Monday, March 9th. The stock was sold at an average price of $485.01, for a total transaction of $312,831.45. Following the completion of the sale, the senior vice president directly owned 1,613 shares of the company's stock, valued at approximately $782,321.13. The trade was a 28.57% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Mark Brosius also recently made the following trade(s):
- On Thursday, March 5th, Mark Brosius sold 648 shares of Intuitive Surgical stock. The stock was sold at an average price of $495.20, for a total transaction of $320,889.60.
- On Wednesday, March 4th, Mark Brosius sold 2,362 shares of Intuitive Surgical stock. The shares were sold at an average price of $498.68, for a total transaction of $1,177,882.16.
- On Tuesday, March 3rd, Mark Brosius sold 648 shares of Intuitive Surgical stock. The stock was sold at an average price of $488.10, for a total value of $316,288.80.
- On Monday, December 15th, Mark Brosius sold 464 shares of Intuitive Surgical stock. The shares were sold at an average price of $548.49, for a total value of $254,499.36.
- On Friday, December 12th, Mark Brosius sold 4,500 shares of Intuitive Surgical stock. The stock was sold at an average price of $547.36, for a total value of $2,463,120.00.
Intuitive Surgical Stock Performance
Shares of ISRG opened at $485.85 on Wednesday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $603.88. The stock has a market capitalization of $172.54 billion, a price-to-earnings ratio of 61.58, a PEG ratio of 3.81 and a beta of 1.66. The stock has a 50 day moving average price of $518.26 and a 200 day moving average price of $512.74.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating analysts' consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same quarter last year, the firm posted $2.21 EPS. The firm's revenue for the quarter was up 18.8% on a year-over-year basis. On average, analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.
Wall Street Analyst Weigh In
Several analysts recently issued reports on the stock. The Goldman Sachs Group reaffirmed a "buy" rating and set a $714.00 price objective on shares of Intuitive Surgical in a research note on Friday, January 9th. BTIG Research reiterated a "buy" rating and set a $616.00 price objective on shares of Intuitive Surgical in a research report on Friday, January 23rd. Royal Bank Of Canada raised their target price on Intuitive Surgical from $625.00 to $650.00 and gave the stock an "outperform" rating in a research note on Wednesday, December 17th. Sanford C. Bernstein lifted their price target on Intuitive Surgical from $740.00 to $750.00 and gave the stock an "outperform" rating in a report on Friday, January 23rd. Finally, Barclays set a $712.00 price target on shares of Intuitive Surgical and gave the company an "overweight" rating in a research report on Monday, January 26th. Two analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $615.86.
Get Our Latest Analysis on Intuitive Surgical
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of ISRG. SteelPeak Wealth LLC raised its stake in Intuitive Surgical by 28.7% in the third quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider's stock valued at $18,781,000 after buying an additional 9,364 shares in the last quarter. Atlantic Union Bankshares Corp boosted its position in shares of Intuitive Surgical by 19.3% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider's stock worth $10,179,000 after acquiring an additional 3,676 shares in the last quarter. World Investment Advisors increased its holdings in shares of Intuitive Surgical by 238.3% in the 3rd quarter. World Investment Advisors now owns 5,399 shares of the medical equipment provider's stock valued at $2,415,000 after acquiring an additional 3,803 shares during the last quarter. E. Ohman J or Asset Management AB raised its position in shares of Intuitive Surgical by 4.1% during the 3rd quarter. E. Ohman J or Asset Management AB now owns 28,306 shares of the medical equipment provider's stock worth $12,659,000 after acquiring an additional 1,123 shares in the last quarter. Finally, Valley Wealth Managers Inc. raised its position in shares of Intuitive Surgical by 52.7% during the 3rd quarter. Valley Wealth Managers Inc. now owns 4,084 shares of the medical equipment provider's stock worth $1,826,000 after acquiring an additional 1,409 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.
Intuitive Surgical Company Profile
(
Get Free Report)
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
